First monoclonal antibody treatment for COVID approved

The TGA has announced its approval of the first monoclonal antibody treatment for COVID-19 in Australia Australians with COVID-19 who are at risk of hospitalisation will now have access to an additional antibody treatment, as TGA announced on Friday that it has granted provisional approval for sotrovimab to be used in Australia. According to a

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous ‘They can be executed:’ anti-vaxxer threatens pharmacists
Next Medicines the weak link in strong supply chain: report